Lexeo Therapeutics Aktie
WKN DE: A3EXD2 / ISIN: US52886X1072
12.05.2025 13:28:59
|
Lexeo Therapeutics, Inc. Q1 Loss Increases, Misses Estimates
(RTTNews) - Lexeo Therapeutics, Inc. (LXEO) revealed Loss for its first quarter that increased from the same period last year and missed the Street estimates.
The company's bottom line totaled -$32.66 million, or -$0.99 per share. This compares with -$21.68 million, or -$0.77 per share, last year.
Analysts on average had expected the company to earn -$0.77 per share. Analysts' estimates typically exclude special items.
Lexeo Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$32.66 Mln. vs. -$21.68 Mln. last year. -EPS: -$0.99 vs. -$0.77 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Lexeo Therapeutics Inc Regsitered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Lexeo Therapeutics Inc Regsitered Shsmehr Analysen
Aktien in diesem Artikel
Lexeo Therapeutics Inc Regsitered Shs | 6,66 | -1,62% |
|